Table 1.
The use rates of the prescribed medications based on their metabolic mechanism in the case group and their effects on the serum level of the studied elements
| Medications | n (%) | Calcium | Phosphorus | Vitamin D3 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Serum level | <8.5 n (%) | 8.5-10.5 n (%) n(%) | >10.5 n (%) | Sig | Serum level | <3.5 n (%) | 3.5-5.5 n (%) | >5.5 n (%) | Sig | Serum level | Deficiency | |||||
|
Yes
n (%) |
No
n (%) |
Sig | ||||||||||||||
| Stimulant | Phenytoin | 5(8.33) | 9.83±0.69 | 1(4.8) | 17(81) | 3(14.3) | 0.222 | 5.19±0.96 | 1(4.8) | 11(52.4) | 9(42.9) | 0.388 | 27.19±10.82 | 14(66.7) | 7(33.3) | 0.070 |
| Carbamazepine | 3(5) | |||||||||||||||
| Phenobarbital | 2(3.33) | |||||||||||||||
| Primidone | 11(18.33) | |||||||||||||||
| Non-Stimulant | Na Valproate | 19(31.7) | 9.84±1.51 | 5(12.8) | 23(59) | 11(28.2) | 5.14±1.05 | 2(5.1) | 27(69.2) | 10(25.6) | 33.53±11.26 | 15(38.5) | 24(61.5) | |||
| Levetiracetam | 14(23.3) | |||||||||||||||
| Topiramate | 5(8.3) | |||||||||||||||
| Ethosuximide | 1(1.7) | |||||||||||||||